-- Israel Stocks: Magic, Mellanox, Teva, Ratio, EZchip, Avner
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-07-18T14:31:17Z
-- http://www.bloomberg.com/news/2012-07-18/israel-stocks-magic-mellanox-teva-ratio-ezchip-avner.html
Israel ’s benchmark  TA-25 index 
dropped for a fifth time in six days, retreating 0.2 percent to
1,057.42 at the 4:30 p.m. close in Tel Aviv. Investors traded
about 737 million shekels ($184 million) of shares and
convertible securities, according to bourse data.  The following stocks rose or fell. Symbols are in
parentheses.  EZchip Semiconductor Ltd. (EZCH)   dropped 3.1 percent,
the most since July 15, to 129.7 shekels, or the equivalent of
$32.30. The New York-traded shares of the Israeli developer of
network processors dropped 2.7 percent at $32.48 yesterday.  Magic Software Enterprises Ltd. (MGIC)   slid 4.8 percent
to 19.15 shekels, or the equivalent of $4.77, the lowest since
Nov. 27. The technology company’s U.S.-traded shares fell 6.1
percent to $4.80 yesterday.  Mellanox Technologies Ltd. (MLNX)   declined 4 percent to
253.5 shekels, or the equivalent of $63.13, the lowest level
since June 14. The New York-traded stock of the Israeli
developer of technology used to transfer and store data, dropped
5.5 percent to $62.24 yesterday.  Pluristem Therapeutics Inc. (PSTI)   advanced 4 percent,
the most since July 3, to 9.88 shekels. The developer of stem-
cell therapies said it partnered with CPC Clinical Research on
an peripheral artery disease Phase II study.  Ratio Oil Exploration 1992 LP (RATIL)   rose as much as
6.3 percent and closed 1.7 percent higher at 0.242 shekel.
Globes business daily reported a deal for a well in  Mozambique 
signifies a higher value for the Leviathan well in which the oil
and gas exploration company is a partner.  Avner Oil Exploration
LLP (AVNRL)   and  Delek Drilling-LP (DEDRL)  , also partners
in the Leviathan field, advanced 1.6 percent and 1.9 percent,
respectively.  Teva Pharmaceutical Industries Ltd. (TEVA)   gained 1.9
percent to 168.2 shekels, or the equivalent of $41.88. The U.S.-
traded shares of the world’s largest generic drugmaker rose 2.9
percent to $42.34 yesterday.  To contact the reporter on this story:
Shoshanna Solomon in  Tel Aviv  at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  